Article
Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation.
Journal of cardiovascular electrophysiology - 1 Mar 2011
Alcalai Ronny, Wakimoto Hiroko, Arad Michael, Planer David, Konno Tetsuo, Wang Libin, Seidman Jon G, Seidman Christine E, Berul Charles I
Abstract excerpt
BACKGROUND: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a familial arrhythmic syndrome caused by mutations in genes encoding the calcium-regulation proteins cardiac ryanodine receptor (RyR2) or calsequestrin-2 (CASQ2). Mechanistic studies indicate that CPVT is mediated by diastolic Ca(2+) overload and increased Ca(2+) leak through the RyR2 channel, implying that treatment targeting these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
